Hospitalized Valley patients with COVID-19 were able to participate in the phase 2 study of Merck’s molnu ...
Hospitalized Valley patients with COVID-19 were able to participate in the phase 2 study of Merck’s molnu ...
Hospitalized Valley patients with COVID-19 were able to participate in the phase 2 study of Merck’s molnupiravir anti-viral treatment through the leadership of Valley’s pulmonary and clinical research ...
Copyright 2016 Valley Medical Center.
All rights reserved.